A PHASE IIB STUDY OF THE EFFICACY AND SAFETY OF LB80380 VS ENTECAVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lai, C. L. | - |
dc.contributor.author | Ahn, S. H. | - |
dc.contributor.author | Lee, K. S. | - |
dc.contributor.author | Um, S. H. | - |
dc.contributor.author | Cho, M. | - |
dc.contributor.author | Yoon, S. K. | - |
dc.contributor.author | Lee, J. W. | - |
dc.contributor.author | Park, N. W. | - |
dc.contributor.author | Kwon, Y. O. | - |
dc.contributor.author | Sohn, J. H. | - |
dc.contributor.author | Lee, J. Y. | - |
dc.contributor.author | Park, H. E. | - |
dc.contributor.author | Kim, J. A. | - |
dc.contributor.author | Han, K. H. | - |
dc.contributor.author | Yuen, M. F. | - |
dc.date.available | 2021-02-15T03:15:58Z | - |
dc.date.issued | 201103 | - |
dc.identifier.issn | 0168-8278 | - |
dc.identifier.issn | 1600-0641 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/50035 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.title | A PHASE IIB STUDY OF THE EFFICACY AND SAFETY OF LB80380 VS ENTECAVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B | - |
dc.type | Conference | - |
dc.identifier.doi | 10.1016/S0168-8278(11)61355-X | - |
dc.citation.title | JOURNAL OF HEPATOLOGY | - |
dc.citation.startPage | S535 | - |
dc.citation.endPage | S535 | - |
dc.citation.conferenceName | 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL) | - |
dc.citation.conferencePlace | 네델란드 | - |
dc.citation.conferencePlace | Berlin, GERMANY | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.